Universal Flu Vaccine Shows 95% Efficacy in Final Trials
A universal flu vaccine that protects against all influenza strains has shown 95% efficacy in Phase 3 trials. The vaccine could eliminate the need for annual flu shots and provide protection against future pandemic strains.
Universal flu vaccine success
Trial Results
The vaccine showed 95% efficacy against all tested influenza strains in a 30,000-participant trial. Protection lasted at least three years, eliminating the need for annual vaccination.
Broad Protection
Unlike current vaccines targeting variable surface proteins, the universal vaccine targets conserved regions that are common to all influenza viruses, including potential pandemic strains.
Public Health Impact
Flu kills 290,000-650,000 people annually worldwide. A universal vaccine could save hundreds of thousands of lives each year and prevent future pandemics.
A universal flu vaccine with 95% efficacy in Phase 3 trials could eliminate annual flu shots and prevent future pandemics by offering broad protection against all influenza strains.
Leave a Comment
Your email address will not be published. Required fields are marked *
